Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

Vertiflex Procedure indirect decompression system spacers.

The Vertiflex™ Procedure†

Superion™ Indirect Decompression System

Setting the standard of care for lumbar spinal stenosis (LSS)

The Vertiflex Procedure is redefining the treatment of LSS for patients. It provides patients with a clinically proven, minimally invasive solution that is designed to deliver long-term relief from the leg and back pain associated with LSS. This Level 1 evidence-based procedure is supported by data from patients who reported successful outcomes up to five years.

Clinically proven for LSS

The Vertiflex Procedure underwent one of the most rigorous studies on Lumbar Spinal Stenosis. 470 patients were enrolled in an Investigational Device Exemption or IDE trial at 29 sites with a 24-month follow-up and annually thereafter through 60 months.1

Patient access

Most patients indicated for the Vertiflex Procedure have insurance coverage through original Medicare and a growing number of private health plans.2,3 Discover ways you can identify appropriate candidates for the Vertiflex Procedure and support patient access to care.  

Indications, safety, and warnings

Read the Superion Indirect Decompression System Indications for Use, Precautions and other Safety Information.

Read more about the Vertiflex Procedure MRI Compatibility.

† Superion™ Indirect Decompression System

References:

1. Nunley PD, Patel VV, Orndorff DG, Lavelle WF, Block JE, Geisler FH. Five-year durability of stand-alone interspinous process decompression for lumbar spinal stenosis. Clin Interv Aging. 2017;12:1409–1417. (N = 88)

2. Benefits are made available through Original Medicare, with coverage provided by statute under the Social Security Act §1862(a)(1)(A). Beneficiaries must always meet medical necessity criteria, as reflected within physician clinical notes.

3. As of April 12, 2022: BCBS Michigan, Highmark BCBS, Inland Empire Health Plan, Dean Health plan and its subsidiaries\, Wellcare Health Plans, Ventura County Health Plan, Emblem Health, Prevea360, Paramount Healthcare and Blue Shield of California (retired non-coverage policy; maintains silent coverage based upon medical necessity). Use of Boston Scientific’s Reimbursement Center for benefit verification, prior authorization and appeals is encouraged for all cases.